![]() Global Gastrointestinal Endoscopy Market
The global gastrointestinal endoscopy market, is expected to reach USD 18,798,321.84 thousand by 2032 from USD 12,066,210.00 thousand in 2024, growing at a substantial CAGR of 5.8% in the forecast ... もっと見る
![]()
※当ページの内容はウェブ更新時の情報です。
SummaryThe global gastrointestinal endoscopy market, is expected to reach USD 18,798,321.84 thousand by 2032 from USD 12,066,210.00 thousand in 2024, growing at a substantial CAGR of 5.8% in the forecast period of 2025 to 2032.Market Segmentation: Global Gastrointestinal Endoscopy Market, Product (Gastrointestinal Endoscopes & Systems and Gastrointestinal Endotherapy), Application (Treatment and Diagnosis), Procedure Type (Colonoscopy, Gastroscopy, Duodenoscopy, Enteroscopy, Sigmoidoscopy and Others), Usability (Reusable and Disposable/ Single Use), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Laboratories, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (U.S., Canada, Mexico, Germany, U.K., France, Russia, Italy, Spain, Turkey, Poland, Netherlands, Switzerland, And Rest Of Europe, China, Japan, India, Australia, South Korea, Singapore, Thailand, Philippines, Malaysia, Indonesia, Vietnam, Rest Of Asia-Pacific, Brazil, Argentina, And Rest Of South America, Saudi Arabia, U.A.E., South Africa, Egypt, Kuwait, Israel, And Rest Of Middle East And Africa) -Industry Trends & Forecast To 2032 Overview of the Global Gastrointestinal Endoscopy are: Driver • Rising Prevalence of Gastrointestinal Disorders Restrain • High Cost of Equipment and Procedures Opportunity • Growing Emphasis on Early Colorectal Cancer Detection Market Players: The key market players for global Gastrointestinal Endoscopy are listed below: • Medtronic (Ireland) • Stryker (U.S.) • Johnson & Johnson Services, Inc. (U.S.) • Boston Scientific Corporation (U.S.) • Cook (U.S.) • CONMED Corporation (U.S.) • STERIS (U.S.) • Henry Schein, Inc. (U.S.) • CapsoVision, Inc. (U.S.) • Teleflex Incorporated (U.S.) • FUJIFILM Holdings Corporation (Japan) • Olympus Corporation (Japan) • Hoya Corporation (Japan) • Smith+Nephew (UK) • Ambu A/S (Denmark) • SonoScape Medical Corp (China) • KLS Martin Group (Germany) • Laborie (Canada) • Micro-Tech Endoscopy (China) • Jiangsu Vedkang (China) • JINSHAN Science & Technology (China) • INTROMEDIC (South Korea) • Ovesco Endoscopy AG (Germany) • Erbe Elektromedizin GmbH (Germany) • Mitra Industries Pvt. Ltd. (India) Table of ContentsTABLE OF CONTENTS1 INTRODUCTION 94 1.1 OBJECTIVES OF THE STUDY 94 1.2 MARKET DEFINITION 94 1.3 OVERVIEW OF THE GLOBAL GASTROINTESTINAL ENDOSCOPY MARKET 94 1.4 LIMITATIONS 96 1.5 MARKETS COVERED 96 2 MARKET SEGMENTATION 99 2.1 MARKETS COVERED 99 2.2 GEOGRAPHICAL SCOPE 100 2.3 YEARS CONSIDERED FOR THE STUDY 101 2.4 CURRENCY AND PRICING 101 2.5 DBMR TRIPOD DATA VALIDATION MODEL 102 2.6 MULTIVARIATE MODELLING 105 2.7 PRODUCT LIFELINE CURVE 106 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 107 2.9 DBMR MARKET POSITION GRID 108 2.10 VENDOR SHARE ANALYSIS 109 2.11 MARKET END USER COVERAGE GRID 110 2.12 SECONDARY SOURCES 111 2.13 ASSUMPTIONS 111 3 EXECUTIVE SUMMARY 112 4 PREMIUM INSIGHTS 117 4.1 PESTAL ANALYSIS 120 4.2 PORTERS FIVE FORCES ANALYSIS 121 4.3 INDUSTRY INSIGHTS 122 4.3.1 MICRO AND MACROECONOMIC FACTORS 122 4.3.2 PENETRATION AND GROWTH PROSPECT MAPPING 122 4.3.3 KEY PRICING STRATEGIES 122 4.3.4 COST ANALYSIS BREAKDOWN 122 4.3.5 TECHNOLOGY ROADMAP 122 4.3.6 OPPUTUNITY MAP ANALYSIS 123 4.3.7 PRICING ANALYSIS 123 4.3.8 COMPETITOR’S MODEL ANALYSIS 123 4.3.9 HEALTHCARE ECONOMY 123 4.3.9.1 HEALTHCARE EXPENDITURE 123 4.3.9.2 CAPITAL EXPENDITURE 123 4.3.9.3 CAPEX TRENDS 124 4.3.9.4 CAPEX ALLOCATION 124 4.3.9.5 FUNDING SOURCES 124 4.3.9.6 INDUSTRY BENCHMARKS 124 4.3.9.7 GDP RATIO IN OVERALL GDP 124 4.3.9.8 HEALTHCARE SYSTEM STRUCTURE 125 4.3.9.9 GOVERNMENT POLICIES 125 4.3.9.10 ECONOMIC DEVELOPMENT 125 4.4 CURRENT TARIFF RATE (S) IN TOP-5 COUNTRY MARKETS 126 4.4.1 OUTLOOK: LOCAL PRODUCTION V/S IMPORT RELIANCE 126 4.4.2 VENDOR SELECTION CRITERIA DYNAMICS 127 4.4.3 IMPACT ON SUPPLY CHAIN 127 4.4.3.1 RAW MATERIAL PROCUREMENT 128 4.4.3.2 MANUFACTURING AND PRODUCTION 128 4.4.3.3 LOGISTICS AND DISTRIBUTION 129 4.4.3.4 PRICE PITCHING AND POSITION OF MARKET 129 4.4.4 INDUSTRY PARTICIPANTS: PROACTIVE MOVES 130 4.4.4.1 SUPPLY CHAIN OPTIMIZATION 130 4.4.4.2 JOINT VENTURE ESTABLISHMENTS 131 4.4.5 IMPACT ON PRICES 132 4.4.6 REGULATORY INCLINATION 132 4.4.6.1 GEOPOLITICAL SITUATION 133 4.4.6.2 TRADE PARTNERSHIPS BETWEEN THE COUNTRIES 133 4.4.6.3 FREE TRADE AGREEMENTS 134 4.4.6.4 ALLIANCES ESTABLISHMENTS 134 4.4.6.5 STATUS ACCREDITATION (INCLUDING MFTN) 135 4.4.6.6 DOMESTIC COURSE OF CORRECTION 135 4.4.6.7 INCENTIVE SCHEMES TO BOOST PRODUCTION OUTPUTS 136 4.4.6.8 ESTABLISHMENT OF SPECIAL ECONOMIC ZONES/INDUSTRIAL PARKS 137 4.4.7 PRICE INDEX 137 4.5 INNOVATION TRACKER AND STRATEGIC ANALYSIS 138 4.6 SUPPLY CHAIN ECOSYSTEM 140 4.7 COMPANY EVALUATION QUADRANT 141 5 REGULATORY COMPLIANCE 142 5.1 REGULATORY AUTHORITIES 142 5.2 REGULATORY CLASSIFICATIONS 143 5.3 REGULATORY SUBMISSIONS 144 5.4 INTERNATIONAL HARMONIZATION 144 5.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS 144 5.6 REGULATORY CHALLENGES AND STRATEGIES 144 6 MARKET OVERVIEW 145 6.1 DRIVERS 147 6.1.1 RISING PREVALENCE OF GASTROINTESTINAL DISORDERS 147 6.1.2 AGING POPULATION DRIVING INCREASED DEMAND FOR GI ENDOSCOPY 148 6.1.3 TECHNOLOGICAL ADVANCEMENTS ENHANCING GI ENDOSCOPY PROCEDURES 149 6.1.4 RISING AWARENESS AND EXPANDED SCREENING PROGRAMS FOR GASTROINTESTINAL ENDOSCOPY 150 6.2 RESTRAINTS 151 6.2.1 HIGH COST OF EQUIPMENT AND PROCEDURES 151 6.2.2 RISK OF PROCEDURE-RELATED COMPLICATIONS 152 6.3 OPPORTUNITIES 153 6.3.1 GROWING EMPHASIS ON EARLY COLORECTAL CANCER DETECTION 153 6.3.2 GROWING ADOPTION OF HOME-BASED AND CAPSULE ENDOSCOPY SOLUTIONS 154 6.3.3 INCREASING PREVALENCE AND ADVANCEMENTS IN PERSONALIZED THERAPEUTIC ENDOSCOPY 155 6.4 CHALLENGES 156 6.4.1 LIMITED ACCESS TO GI ENDOSCOPY IN RURAL AREAS 156 6.4.2 COMPLEXITIES IN ENDOSCOPE REPROCESSING AND STERILIZATION PROCESSES 157 7 GLOBAL GASTROINTESTINAL ENDOSCOPY MARKET, BY PRODUCT 158 7.1 OVERVIEW 159 7.2 GASTROINTESTINAL ENDOSCOPES & SYSTEMS 162 7.2.1 ENDOSCOPES 164 7.2.1.1 COLONOSCOPES 165 7.2.1.2 GASTROSCOPES 165 7.2.1.3 DUODENOSCOPES 165 7.2.1.4 ENTEROSCOPES 165 7.2.1.5 SIGMOIDOSCOPES 165 7.2.1.6 RESECTOSCOPES 165 7.2.2 FLEXIBLE 166 7.2.3 RIGID 166 7.2.4 SEMI RIGID 166 7.2.4.1 VIDEO 167 7.2.4.2 FIBRE 167 7.2.4.3 ULTRASONIC 167 7.2.5 VISUALIZATION SYSTEMS 168 7.2.5.1 FLUORESCENCE IMAGING SYSTEMS 168 7.2.5.1.1 NIR LIGHT FLUORESCENCE IMAGING SYSTEM 169 7.2.5.1.2 WHITE LIGHT FLUORESCENCE IMAGING SYSTEM 169 7.2.5.1.3 UV LIGHT FLUORESCENCE IMAGING SYSTEMS 169 7.2.5.1.4 CONFOCAL LASER ENDOSCOPY IMAGING SYSTEMS 169 7.2.5.1.5 PROBE-BASED CLE (PCLE) 170 7.2.5.1.6 BUILT-IN DEVICE CLE (ECLE) 170 7.2.5.2 HIGH DEFINITION (HD) VISUALIZATION SYSTEMS 171 7.2.5.2.1 2D SYSTEMS 171 7.2.5.2.2 3D SYSTEMS 171 7.2.5.3 STANDARD DEFINITION (SD) VISUALIZATION SYSTEMS 172 7.2.5.3.1 ENDOSCOPIC ULTRASONOGRAPHY SYSTEMS 172 7.2.5.3.2 CAPSULE ENDOSCOPES 172 7.2.5.3.3 ULTRASOUND DEVICE 172 7.3 GASTROINTESTINAL ENDOTHERAPY 173 7.3.1 ERCP DEVICES 175 7.3.2 BIOPSY DEVICE 175 7.3.3 STENTING AND DILATION DEVICE 175 7.3.4 HOMEOSTASIS DEVICES 175 7.3.4.1 LIGATION DEVICES 176 7.3.4.2 PROBES 176 7.3.4.3 SCLEROTHERAPY NEEDLES 176 7.3.5 RETRIEVAL DEVICES 177 7.3.6 CAMERA HEAD 177 7.3.7 ANTI-REFLUX DEVICES 177 7.3.7.1 TRANSORAL INCISIONLESS FUNDOPLICATION (TIF) DEVICES 177 7.3.7.2 TRANSESOPHAGEAL RADIOFREQUENCY (RF) ANTI-REFLUX DEVICES 177 7.3.8 OTHERS 178 8 GLOBAL GASTROINTESTINAL ENDOSCOPY MARKET, BY PROCEDURE TYPE 179 8.1 OVERVIEW 180 8.2 COLONOSCOPY 183 8.3 GASTROSCOPY 184 8.4 DUODENOSCOPY 184 8.5 ENTEROSCOPY 185 8.6 SIGMOIDOSCOPY 185 8.7 OTHERS 186 9 GLOBAL GASTROINTESTINAL ENDOSCOPY MARKET, BY USABILITY 187 9.1 OVERVIEW 188 9.2 REUSABLE 191 9.3 DISPOSABLE/ SINGLE USE 192 10 GLOBAL GASTROINTESTINAL ENDOSCOPY MARKET, BY APPLICATION 193 10.1 OVERVIEW 194 10.2 TREATMENT 197 10.3 DIAGNOSIS 198 11 GLOBAL GASTROINTESTINAL ENDOSCOPY MARKET, BY END USER 199 11.1 OVERVIEW 200 11.2 HOSPITALS 204 11.3 AMBULATORY SURGICAL CENTERS 205 11.4 SPECIALTY CLINICS 206 11.5 LABORATORIES 206 11.6 OTHERS 207 12 GLOBAL GASTROINTESTINAL ENDOSCOPY MARKET, BY DISTRIBUTION CHANNEL 208 12.1 OVERVIEW 209 12.2 DIRECT TENDER 212 12.3 RETAIL SALES 213 12.4 OTHERS 213 13 GLOBAL GASTROINTESTINAL ENDOSCOPY MARKET, BY REGION 214 13.1 OVERVIEW 215 13.2 NORTH AMERICA 218 13.2.1 U.S. 234 13.2.2 CANADA 249 13.2.3 MEXICO 263 13.3 EUROPE 277 13.3.1 GERMANY 292 13.3.2 FRANCE 305 13.3.3 U.K. 319 13.3.4 ITALY 332 13.3.5 SPAIN 344 13.3.6 RUSSIA 356 13.3.7 SWITZERLAND 368 13.3.8 NETHERLANDS 380 13.3.9 POLAND 392 13.3.10 TURKEY 404 13.3.11 REST OF EUROPE 417 13.4 ASIA-PACIFIC 418 13.4.1 CHINA 432 13.4.2 JAPAN 445 13.4.3 INDIA 458 13.4.4 SOUTH KOREA 471 13.4.5 AUSTRALIA 483 13.4.6 INDONESIA 495 13.4.7 THAILAND 508 13.4.8 MALAYSIA 520 13.4.9 PHILIPPINES 532 13.4.10 SINGAPORE 544 13.4.11 VIETNAM 557 13.4.12 REST OF ASIA-PACIFIC 569 13.5 SOUTH AMERICA 570 13.5.1 BRAZIL 584 13.5.2 ARGENTINA 597 13.5.3 REST OF SOUTH AMERICA 610 13.6 MIDDLE EAST AND AFRICA 611 13.6.1 SOUTH AFRICA 625 13.6.2 SAUDI ARABIA 638 13.6.3 U.A.E 651 13.6.4 EGYPT 664 13.6.5 ISRAEL 676 13.6.6 KUWAIT 689 13.6.7 REST OF MIDDLE EAST AND AFRICA 702 14 GLOBAL GASTROINTESTINAL ENDOSCOPY MARKET: COMPANY LANDSCAPE 703 14.1 COMPANY SHARE ANALYSIS: GLOBAL 703 14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 704 14.3 COMPANY SHARE ANALYSIS: EUROPE 705 14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 706 15 SWOT ANALYSIS 707 16 COMPANY PROFILES 708 16.1 OLYMPUS CORPORATION 708 16.1.1 COMPANY SNAPSHOT 708 16.1.2 REVENUE ANALYSIS 708 16.1.3 COMPANY SHARE ANALYSIS 709 16.1.4 PRODUCT PORTFOLIO 709 16.1.5 RECENT DEVELOPMENT/NEWS 711 16.2 FUJIFILM HOLDINGS CORPORATION 712 16.2.1 COMPANY SNAPSHOT 712 16.2.2 REVENUE ANALYSIS 712 16.2.3 COMPANY SHARE ANALYSIS 713 16.2.4 PRODUCT PORTFOLIO 713 16.2.5 RECENT DEVELOPMENTS/NEWS 714 16.3 MEDTRONIC 716 16.3.1 COMPANY SNAPSHOT 716 16.3.2 REVENUE ANALYSIS 716 16.3.3 COMPANY SHARE ANALYSIS 717 16.3.4 PRODUCT PORTFOLIO 717 16.3.5 RECENT DEVELOPMENTS/NEWS 719 16.4 JOHNSON & JOHNSON SERVICES, INC. 720 16.4.1 COMPANY SNAPSHOT 720 16.4.2 REVENUE ANALYSIS 720 16.4.3 COMPANY SHARE ANALYSIS 721 16.4.4 PRODUCT PORTFOLIO 721 16.4.5 RECENT DEVELOPMENTS 721 16.5 STRYKER 722 16.5.1 COMPANY SNAPSHOT 722 16.5.2 REVENUE ANALYSIS 722 16.5.3 COMPANY SHARE ANALYSIS 723 16.5.4 PRODUCT PORTFOLIO 723 16.5.5 RECENT DEVELOPMENT 724 16.6 AMBU AS 725 16.6.1 COMPANY SNAPSHOT 725 16.6.2 REVENUE ANALYSIS 725 16.6.3 PRODUCT PORTFOLIO 726 16.6.4 RECENT DEVELOPMENTS/NEWS 727 16.7 ANX ROBOTICS 728 16.7.1 COMPANY SNAPSHOT 728 16.7.2 PRODUCT PORTFOLIO 728 16.7.3 RECENT DEVELOPMENTS/NEWS 729 16.8 BOSTON SCIENTIFIC CORPORATION 730 16.8.1 COMPANY SNAPSHOT 730 16.8.2 REVENUE ANALYSIS 730 16.8.3 PRODUCT PORTFOLIO 731 16.8.4 RECENT DEVELOPMENT 733 16.9 CAPSOVISION, INC. 734 16.9.1 COMPANY SNAPSHOT 734 16.9.2 PRODUCT PORTFOLIO 734 16.9.3 RECENT DEVELOPMENTS/NEWS 735 16.10 CONMED CORPORATION 736 16.10.1 COMPANY SNAPSHOT 736 16.10.2 PRODUCT PORTFOLIO 737 16.10.3 RECENT DEVELOPMENTS 740 16.11 COOK 741 16.11.1 COMPANY SNAPSHOT 741 16.11.2 PRODUCT PORTFOLIO 741 16.11.3 RECENT DEVELOPMENT/NEWS 743 16.12 DAICHUAN MEDICAL 744 16.12.1 COMPANY SNAPSHOT 744 16.12.2 PRODUCT PORTFOLIO 744 16.12.3 RECENT DEVELOPMENT 744 16.13 ERBE ELEKTROMEDIZIN GMBH 745 16.13.1 COMPANY SNAPSHOT 745 16.13.2 PRODUCT PORTFOLIO 745 16.13.3 RECENT DEVELOPMENT 747 16.14 GONGJIANG ENDOSCOPY INSTRUMENTS CO., LTD 748 16.14.1 COMPANY SNAPSHOT 748 16.14.2 PRODUCT PORTFOLIO 748 16.14.3 RECENT DEVELOPMENT 748 16.15 HENRY SCHEIN, INC. 749 16.15.1 COMPANY SNAPSHOT 749 16.15.2 REVENUE ANALYSIS 749 16.15.3 PRODUCT PORTFOLIO 750 16.15.4 RECENT DEVELOPMENT 750 16.16 HOYA CORPORATION. 751 16.16.1 COMPANY SNAPSHOT 751 16.16.2 REVENUE ANALYSIS 751 16.16.3 PRODUCT PORTFOLIO 752 16.16.4 RECENT DEVELOPMENT 754 16.17 INTROMEDIC 755 16.17.1 COMPANY SNAPSHOT 755 16.17.2 PRODUCT PORTFOLIO 755 16.17.3 RECENT DEVELOPMENT 755 16.18 JIANGSU VEDKANG MEDICAL SCIENCE AND TECHNOLOGY CO., LTD 756 16.18.1 COMPANY SNAPSHOT 756 16.18.2 PRODUCT PORTFOLIO 756 16.18.3 RECENT DEVELOPMENT 758 16.19 JINSHAN SCIENCE & TECHNOLOGY 759 16.19.1 COMPANY SNAPSHOT 759 16.19.2 PRODUCT PORTFOLIO 759 16.19.3 RECENT DEVELOPMENT/NEWS 761 16.20 KLS MARTIN GROUP 762 16.20.1 COMPANY SNAPSHOT 762 16.20.2 PRODUCT PORTFOLIO 762 16.20.3 RECENT DEVELOPMENT 764 16.21 LABORIE 765 16.21.1 COMPANY SNAPSHOT 765 16.21.2 PRODUCT PORTFOLIO 765 16.21.3 RECENT DEVELOPMENT 768 16.22 MECANMEDICAL 769 16.22.1 COMPANY SNAPSHOT 769 16.22.2 PRODUCT PORTFOLIO 769 16.22.3 RECENT DEVELOPMENT 770 16.23 MICRO-TECH ENDOSCOPY 771 16.23.1 COMPANY SNAPSHOT 771 16.23.2 PRODUCT PORTFOLIO 771 16.23.3 RECENT DEVELOPMENT 773 16.24 MITRA INDUSTRIES PVT. LTD. 774 16.24.1 COMPANY SNAPSHOT 774 16.24.2 PRODUCT PORTFOLIO 774 16.24.3 RECENT DEVELOPMENT 775 16.25 OVESCO ENDOSCOPY AG 776 16.25.1 COMPANY SNAPSHOT 776 16.25.2 PRODUCT PORTFOLIO 776 16.25.3 RECENT DEVELOPMENT 778 16.26 SHAILI ENDOSCOPY 780 16.26.1 COMPANY SNAPSHOT 780 16.26.2 PRODUCT PORTFOLIO 780 16.26.3 RECENT DEVELOPMENT 782 16.27 SMITH+NEPHEW 783 16.27.1 COMPANY SNAPSHOT 783 16.27.2 REVENUE ANALYSIS 783 16.27.3 PRODUCT PORTFOLIO 784 16.27.4 RECENT DEVELOPMENT 784 16.28 SONOSCAPE MEDICAL CORP. 785 16.28.1 COMPANY SNAPSHOT 785 16.28.2 REVENUE ANALYSIS 786 16.28.3 PRODUCT PORTFOLIO 786 16.28.4 RECENT DEVELOPMENT/NEWS 788 16.29 STERIS 789 16.29.1 COMPANY SNAPSHOT 789 16.29.2 REVENUE ANALYSIS 789 16.29.3 PRODUCT PORTFOLIO 790 16.29.4 RECENT DEVELOPMENT 791 16.30 TELEFLEX INCORPORATED. 792 16.30.1 COMPANY SNAPSHOT 792 16.30.2 REVENUE ANALYSIS 792 16.30.3 PRODUCT PORTFOLIO 793 16.30.4 RECENT DEVELOPMENT 794 17 QUESTIONNAIRE 795
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医薬)の最新刊レポート
Data Bridge Market Research社の 医薬分野 での最新刊レポート
よくあるご質問Data Bridge Market Research社はどのような調査会社ですか?データブリッジマーケットリサーチ(Data Bridge Market Research)は500名以上の多様な分野のアナリストが所属するインドの調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|